Morbidity and Mortality Weekly Report (MMWR) Section NavigationCOVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
This report describes safety of the Pfizer-BioNTech COVID-19 vaccine for children aged 5–11 years. // 31.12.2021
Among 15 preliminary reports of myocarditis identified during the analytic period, 11 were verified (by provider interview or medical record review) and met the case definition for myocarditis¶¶¶; of these 11 children, seven recovered, and four were recovering at time of the report. VAERS received two reports of death during the analytic period; both are under review. These deaths occurred in two females, aged 5 and 6 years, both of whom had complicated medical histories and were in fragile health before vaccination. None of the data suggested a causal association between death and vaccination.